Max Robotics — Global Service Robot Directory + US Certification

About

Vineeth Kommidi is a urologic surgeon and researcher focused on advancing the surgical management of kidney cancer, particularly through robotic-assisted techniques. His work centers on optimizing outcomes for complex renal masses, including those with venous tumor thrombus, and refining perioperative care to reduce complications. In a notable 2021 study, Kommidi examined clinical outcomes of robotic-assisted partial nephrectomy for pathologic T3a renal masses with venous tumor thrombus, demonstrating the feasibility and safety of this minimally invasive approach in challenging cases—a contribution that has garnered 5 citations. He has also investigated the use of pre-operative pharmacologic venous thromboembolism prophylaxis for robotic partial nephrectomy, addressing a critical aspect of patient safety. Additionally, Kommidi explored the utility of Clear Cell Likelihood Scores on multiparametric MRI to decrease benign pathology rates in patients with chronic kidney disease being considered for nephron-sparing surgery, presenting these findings at the Journal of Urology. His research, though early in its citation impact, underscores a commitment to evidence-based, patient-centered innovations in urologic oncology, with a focus on preserving renal function while achieving oncologic control.